Cargando…

Predictors of outcome in idiopathic rapidly progressive glomerulonephritis (IRPGN)

BACKGROUND: Small vessel vasculitides are known to follow a devastating course towards end-stage renal disease, unless treated with immunosuppressive regiments. We investigated the value of clinical, histological and immunohistochemical parameters as predictors of outcome at diagnosis in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexopoulos, Efstathios, Gionanlis, Lazaros, Papayianni, Ekaterini, Kokolina, Elizabeth, Leontsini, Maria, Memmos, Dimitrios
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1660564/
https://www.ncbi.nlm.nih.gov/pubmed/17078867
http://dx.doi.org/10.1186/1471-2369-7-16
_version_ 1782131041254768640
author Alexopoulos, Efstathios
Gionanlis, Lazaros
Papayianni, Ekaterini
Kokolina, Elizabeth
Leontsini, Maria
Memmos, Dimitrios
author_facet Alexopoulos, Efstathios
Gionanlis, Lazaros
Papayianni, Ekaterini
Kokolina, Elizabeth
Leontsini, Maria
Memmos, Dimitrios
author_sort Alexopoulos, Efstathios
collection PubMed
description BACKGROUND: Small vessel vasculitides are known to follow a devastating course towards end-stage renal disease, unless treated with immunosuppressive regiments. We investigated the value of clinical, histological and immunohistochemical parameters as predictors of outcome at diagnosis in patients with pauci immune necrotizing glomerulonephritis. METHODS: In 34 patients the percentage and evolution stage of crescents, the presence of glomerular necrosis, the degree or severity of arteriosclerosis, as well as the extent of tubulointerstitial infiltration, interstial fibrosis and tubular atrophy were assessed. Monoclonal antibodies were used to identify infiltrating macrophages, α-SMA(+) and PCNA(+) cells, the expression of integrins α3β1 and LFA-1β, the adhesion molecule ICAM-1, the growth factor TGF-β1 and the terminal complement component C5b-9. RESULTS: 24 pts (70.6%) showed a complete or partial response to the treatment. The follow-up period was 20 ± 22 months. At multivariate analysis, serum CRP (p = 0.024), the intensity of tubular expression of C5b-9 (p < 0.0001) as well as the extent of glomerular and tubular expression of α3β1 integrin (p = 0.001 and 0.008 respectively) independently predicted the response to treatment. The response rate was better in ANCA(+) pts (p = 0.008). The extent of interstitial infiltrate (p < 0.0001), the severity of tubulointerstitial fibrosis (p < 0.0001) and the severity of tubular TGF-β1 expression (p < 0.0001) were independent predictors of long term outcome of renal function. CONCLUSION: Patients with ANCA-associated renal vasculitis seem to respond better to the treatment. Acute phase reactants, such as CRP, implying a more intense parenchymal inflammatory reaction, as well as the intensity of the de novo expression of C5b-9 and the glomerular and tubular expression of α3β1 integrin predict the response to therapy. The severity of TIN lesions and of the tubulo-interstitial TGF-β1 and C5b-9 expression predict an unfavourable outcome.
format Text
id pubmed-1660564
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-16605642006-11-24 Predictors of outcome in idiopathic rapidly progressive glomerulonephritis (IRPGN) Alexopoulos, Efstathios Gionanlis, Lazaros Papayianni, Ekaterini Kokolina, Elizabeth Leontsini, Maria Memmos, Dimitrios BMC Nephrol Research Article BACKGROUND: Small vessel vasculitides are known to follow a devastating course towards end-stage renal disease, unless treated with immunosuppressive regiments. We investigated the value of clinical, histological and immunohistochemical parameters as predictors of outcome at diagnosis in patients with pauci immune necrotizing glomerulonephritis. METHODS: In 34 patients the percentage and evolution stage of crescents, the presence of glomerular necrosis, the degree or severity of arteriosclerosis, as well as the extent of tubulointerstitial infiltration, interstial fibrosis and tubular atrophy were assessed. Monoclonal antibodies were used to identify infiltrating macrophages, α-SMA(+) and PCNA(+) cells, the expression of integrins α3β1 and LFA-1β, the adhesion molecule ICAM-1, the growth factor TGF-β1 and the terminal complement component C5b-9. RESULTS: 24 pts (70.6%) showed a complete or partial response to the treatment. The follow-up period was 20 ± 22 months. At multivariate analysis, serum CRP (p = 0.024), the intensity of tubular expression of C5b-9 (p < 0.0001) as well as the extent of glomerular and tubular expression of α3β1 integrin (p = 0.001 and 0.008 respectively) independently predicted the response to treatment. The response rate was better in ANCA(+) pts (p = 0.008). The extent of interstitial infiltrate (p < 0.0001), the severity of tubulointerstitial fibrosis (p < 0.0001) and the severity of tubular TGF-β1 expression (p < 0.0001) were independent predictors of long term outcome of renal function. CONCLUSION: Patients with ANCA-associated renal vasculitis seem to respond better to the treatment. Acute phase reactants, such as CRP, implying a more intense parenchymal inflammatory reaction, as well as the intensity of the de novo expression of C5b-9 and the glomerular and tubular expression of α3β1 integrin predict the response to therapy. The severity of TIN lesions and of the tubulo-interstitial TGF-β1 and C5b-9 expression predict an unfavourable outcome. BioMed Central 2006-11-01 /pmc/articles/PMC1660564/ /pubmed/17078867 http://dx.doi.org/10.1186/1471-2369-7-16 Text en Copyright © 2006 Alexopoulos et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Alexopoulos, Efstathios
Gionanlis, Lazaros
Papayianni, Ekaterini
Kokolina, Elizabeth
Leontsini, Maria
Memmos, Dimitrios
Predictors of outcome in idiopathic rapidly progressive glomerulonephritis (IRPGN)
title Predictors of outcome in idiopathic rapidly progressive glomerulonephritis (IRPGN)
title_full Predictors of outcome in idiopathic rapidly progressive glomerulonephritis (IRPGN)
title_fullStr Predictors of outcome in idiopathic rapidly progressive glomerulonephritis (IRPGN)
title_full_unstemmed Predictors of outcome in idiopathic rapidly progressive glomerulonephritis (IRPGN)
title_short Predictors of outcome in idiopathic rapidly progressive glomerulonephritis (IRPGN)
title_sort predictors of outcome in idiopathic rapidly progressive glomerulonephritis (irpgn)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1660564/
https://www.ncbi.nlm.nih.gov/pubmed/17078867
http://dx.doi.org/10.1186/1471-2369-7-16
work_keys_str_mv AT alexopoulosefstathios predictorsofoutcomeinidiopathicrapidlyprogressiveglomerulonephritisirpgn
AT gionanlislazaros predictorsofoutcomeinidiopathicrapidlyprogressiveglomerulonephritisirpgn
AT papayianniekaterini predictorsofoutcomeinidiopathicrapidlyprogressiveglomerulonephritisirpgn
AT kokolinaelizabeth predictorsofoutcomeinidiopathicrapidlyprogressiveglomerulonephritisirpgn
AT leontsinimaria predictorsofoutcomeinidiopathicrapidlyprogressiveglomerulonephritisirpgn
AT memmosdimitrios predictorsofoutcomeinidiopathicrapidlyprogressiveglomerulonephritisirpgn